Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on June 9, 2026

Jun. 9, 2026

Legend Senior Living Earns Great Place to Work® Certification™ for Eighth Consecutive Year

Indeterminate GlobeNewswire

Jun. 9, 2026

하와이 최대 IVF 기관, Nucleus IVF+ 네트워크에 합류해 유전 최적화 수요 확대 대응

Indeterminate GlobeNewswire

Jun. 9, 2026

Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Demand for Genetic Optimization Continues to Expand

Indeterminate GlobeNewswire

Jun. 9, 2026

International Myeloma Foundation (IMF) and International Myeloma Working Group (IMWG) to Honor 2026 Kyle and Durie Achievement Awardees, Dr. Hermann Einsele and Dr. Noopur Raje

Indeterminate GlobeNewswire

Jun. 9, 2026

Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

Indeterminate GlobeNewswire

Jun. 9, 2026

PRM and Project Endo Launch National University Health Initiative to Improve Early Endometriosis Recognition on College Campuses

Indeterminate GlobeNewswire

Jun. 9, 2026

SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team

Indeterminate GlobeNewswire

Jun. 9, 2026

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Indeterminate GlobeNewswire

Jun. 9, 2026

The MUHC Foundation’s Le Bal Rouge Gala raises $2,223,306 million to accelerate discovery in health care at the MUHC’s Glen site

Indeterminate GlobeNewswire

Jun. 9, 2026

Le gala Le Bal Rouge de la Fondation du CUSM recueille un montant record de 2 223 306 $ pour accélérer les découvertes en santé au site Glen du CUSM

Indeterminate GlobeNewswire

Jun. 9, 2026

Flyte Announces World Cup Activation Strategy, Targeting Global Travel Demand Surrounding 2026 Tournament

Indeterminate GlobeNewswire

Jun. 9, 2026

Chiesi Global Rare Diseases Announces Health Canada Grants Priority Review for FILSUVEZ® (birch triterpenes) Topical Gel for the Treatment of Epidermolysis Bullosa

Indeterminate GlobeNewswire

Jun. 9, 2026

R1 Appoints Eric Tagliere as Chief Information Officer

Indeterminate GlobeNewswire

Jun. 9, 2026

Vaxart to Participate in BTIG Infectious Disease Day 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

BrainsWay Presents First SWIFT™ Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting

Indeterminate GlobeNewswire

Jun. 9, 2026

CVRx Announces Chief Financial Officer Transition

Indeterminate GlobeNewswire

Jun. 9, 2026

Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China

Indeterminate GlobeNewswire

Jun. 9, 2026

TG Therapeutics Announces Positive Topline Phase 1 Data for Subcutaneous BRIUMVI in Patients with Myasthenia Gravis and Initiation of Potential Registration Directed Randomized Phase 2 Trial

Indeterminate GlobeNewswire

Jun. 9, 2026

Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy

Indeterminate GlobeNewswire

Jun. 9, 2026

Kraig Biocraft Laboratories Sets New All-Time Production Record, Delivering Nearly 2.5 Metric Tons of Recombinant Spider Silk in Single Production Cycle

Indeterminate GlobeNewswire